About the P. vivax information hub
Tafenoquine featured this year as a key innovation in a UHC special report.
Video on life-changing treatment to cure relapsing P. vivax malaria.
The Malaria in Pregnancy (MiP) Library now available on WWARN.
About 8.5 million people are at risk of malaria in Nepal. Despite this progress, there was a 20% increase from 2016 to 2017.
In this study, the prevalence and distribution of G6PD mutations were investigated across Ethiopia with the goal to provide additional information relevant to the use of primaquine in malaria treatment.
This tool assesses the cost-effectiveness of using G6PD RDTs prior to the administration of primaquine.
The vivax after falciparum Study Group was formed in March 2018, with an invitation to interested researchers with relevant data sets.
Areas of focus for this meeting include clinical and epidemiological research, as well as in vitro laboratory studies of the human pathogens P. falciparum and P. vivax.
The immunology of Plasmodium vivax malaria.